Ana Infante

Ana Infante has a diverse work experience spanning multiple companies in the pharmaceutical industry. Ana currently holds the position of Head of Europe Epilepsy & Europe Operations at UCB since April 2022. Prior to this, they served as the Chief of Staff for the Rare Disease Organization at UCB from July 2021 to June 2022.

Ana also has extensive experience at UCB, where they held various roles such as Head of Global Neurology Strategy, Assets & Operations (Neurology Patient Value Unit) from July 2018 to July 2021, Neurology Strategic Partner from February 2018 to July 2021, and Head of Free Motion Patient Value Mission, Global Neurology (Movement Disorder Area Strategy) from March 2015 to February 2018.

Before joining UCB, Ana worked at GSK as the Business Unit Lead for Stiefel@GSK Company from December 2009 to August 2010. Ana also held positions at GSK as Sales & Marketing Manager in Neuroscience and Group Product Manager in Neuroscience from October 2009 to December 2009 and January 2007 to September 2009, respectively.

Ana began their career at Pfizer as a Product Manager in Neurociences, where they worked from 2002 to 2006.

Overall, Ana Infante brings a wealth of experience in neurology and rare diseases, with expertise in strategy development, global operations, and patient value creation.

Ana Infante has a Bachelor's Degree in Pharmacy with a specialization in Biochemistry from Universidad Complutense de Madrid. Ana also has a Post Graduate degree in Pharmaceutical Marketing from IE Business School. Additionally, Ana has completed a Management Programme at IE Business School and obtained a degree in Business Administration and Management from IESE Business School - University of Navarra.